Alnylam earns $3.2M milestone payment from Glaxo
Linkedin

Alnylam earns $3.2M milestone payment from Glaxo

Boston : MA : USA | Jul 30, 2012 at 12:09 PM PDT
Source: Boston Herald
XX XX
Views: Pending
 
C ambridge-based Alnylam Pharmaceuticals said today it has earned a development milestone payment from GlaxoSmithKline totaling $3.2 million. Company officials said the payment is related to progress in the companies' collaboration on the use of VaxiRNA technology for the production of GSK influenza... FULL ARTICLE AT Boston Herald
 
  • Clear
  • Share:
  • Share
  • Clear
  • Clear
  • Clear
  • Clear
 
  • Credibility
  • Wait... Flag
 
 
Advertisement
 

More From Allvoices

Most Commented Reports



Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc. 2008-2014. All rights reserved. Powered by PulsePoint.